This is a snippet of the transcript, sign up to read more.
We did it for two different products. Envoy, a visitor management tool, was bought and deprecated, saving us $250,000. We used the WSD Workplace Service Delivery product, which includes visitor management as part of its suite, allowing us to save money there. We also deprecated Moveworks, which ServiceNow just acquired. We replaced Moveworks with ServiceNow's virtual agent because we had the ITSM Pro SKU. ServiceNow's acquisition of Moveworks changes our strategy, but initially, Moveworks wasn't as native as we wanted with ServiceNow. The Moveworks UI extension was incompatible in several ways. For instance, it couldn't handle complex forms with UI rules, like displaying specific fields based on conditions. It operated at about a 20% success rate for deflecting tickets. I believe this is due to culture. I researched Moveworks and spoke with their leadership team, including Varun Singh. They often engaged with us since we were one of their bigger customers. The success stories I heard with Moveworks were largely due to companies investing in pushing their employees through the Moveworks channel rather than having a democratized approach.
This is a snippet of the transcript, sign up to read more.
Yes, I'll start with the contract negotiation, then move to service usage. In contract negotiation, they have different chargeback models per product. For IT, it's based on the headcount of fulfillers, those actioning tickets. Other products, like Integration Hub, are based on transactions and queries. The core products, WSD, HRSD, LSD, are based on the requester base. On the IT side, we had fewer fulfillers, fewer traditional service desk fulfillers.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research